Physician profile
Robert Parrish King
NPI 1053589671
$8,460.92
in general payments reported to CMS, 2019-2025
7 companies · $77.82 in 2025
The $77.82 reported for 2025 was more than what a typical General Practice (Dentist) provider received nationally (typical 2025 total: $74.60).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $619 · 2020: $90.10 · 2021: $23.07 · 2022: $7,058 · 2023: $410 · 2024: $183 · 2025: $77.82.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $370 · Consulting Fee: $300.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $370.29 |
| Consulting Fee | $300.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biohorizons Implant Systems INC. | $6,798.14 | 2019-2025 | Biohorizons, Biohorizons Dental Implants |
| Dentsply LLC | $946.65 | 2019-2023 | |
| Dentsply Sirona INC | $430.25 | 2019-2024 | Waveone Gold Conform Fit, Prime&Bond Nt Nano-Technology Light Cured Dental Adhesive, Consumable Dentistry |
| Galderma Laboratories, L.P. | $144.37 | 2019 | |
| Align Technology, INC. | $114.58 | 2020-2024 | Invisalign, Itero Element 5d |
| Straumann USA LLC | $17.12 | 2022 | |
| Voco America INC. | $9.81 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robert King listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.